Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision label in the history table updates from v3.6.2 to v3.6.3, indicating a new revision of the study record.
    Difference
    0.1%
    Check dated 2026-07-05T11:46:50.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.6.2, replacing v3.6.0. This reflects a small update to the page’s versioning rather than a change to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-06-28T08:39:00.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The study record now indicates that no more participants are being recruited. The record has been updated to version v3.6.0, replacing the prior revision.
    Difference
    0.3%
    Check dated 2026-06-14T06:18:34.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The version history now displays a new revision entry (v3.5.5) and removes the preceding revision (v3.5.4), reflecting an updated record meta.
    Difference
    0.1%
    Check dated 2026-06-07T03:41:33.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Record History now includes added sections for Adverse Events, Outcome Measures, Participant Flow, and References. A new version entry dated 2026-05-12 indicates updated content in the study record.
    Difference
    0.8%
    Check dated 2026-05-16T09:21:17.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a site or interface release rather than substantive trial-record changes.
    Difference
    0.1%
    Check dated 2026-04-24T22:26:09.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.